Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00203840 · ClinicalTrials.gov registry record

Pediatric Sleep Questionnaire: Normalization and Validation Study

A clinical trial of Sleep Disorders, sponsored by University of Chicago.

Completed
Registry status
325
Enrollment target
1
Study location

NCT00203840: Completed study of Sleep Disorders, sponsored by University of Chicago.

NCT00203840 is a study of Sleep Disorders that has completed, run by University of Chicago. The registered enrollment target is 325 participants, roughly in line with the 312-participant average among 19 other Sleep Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00203840, a study of Sleep Disorders, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
325 participants
Enrollment target
1
Study location

Study Summary

The information gathered from normal pediatric patients seen at the Pediatric Neurology Clinic in the DCAM and LaRabida Children's Hospital will be used to standardize and validate the information gathered from pediatric patients with sleep disorders. This will serve as the information source for a pediatric sleep database.

Primary Outcome

This questionnaire is used to better understand the natural history of sleeping disorders in children.

Conditions Studied

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2004-08
Est. Completion 2016-04
University of Chicago

796 total trials

What the finished NCT00203840 record still lists

NCT00203840 is an observational study that tracks outcomes without assigning an intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 312-participant average among 19 other Sleep Disorders trials with a reported enrollment target.

The record links to 1 condition, with Sleep Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00203840 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00203840 about?

NCT00203840 is a clinical study titled "Pediatric Sleep Questionnaire: Normalization and Validation Study". The information gathered from normal pediatric patients seen at the Pediatric Neurology Clinic in the DCAM and LaRabida Children's Hospital will be used to standardize and validate the information gathered from pediatric patients with sleep disorders. This will serve as the information source for a ...

What is the current status of trial NCT00203840?

This trial is currently completed. The enrollment target is 325 participants. The study started on 2004-08. Estimated completion is 2016-04.

What conditions does trial NCT00203840 study?

This clinical trial studies the following conditions: Sleep Disorders.

Who is sponsoring clinical trial NCT00203840?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00203840 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00203840's enrollment target sits among peer trials

325 5th of 19 higher than 15 of 19 other Sleep Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02543983 · 325 participants · Phase 2

    Neurobiology of Suicide

  • NCT03016819 · 325 participants · Phase 3

    Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • NCT03288207 · 325 participants · NA

    Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

  • NCT04986657 · 325 participants · NA

    Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00203840, the US trial registry maintained by the National Library of Medicine. NCT00203840 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.